Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Elaborate
AddedFeb 15, 2024
UpdatedJun 18, 2026
Elaborate

Elaborate

Seed

Elaborate's award-winning software reduces doctor burnout by managing EMR and patient portal messages, enhancing patient satisfaction.

HQ
New York City, NY, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to alleviate doctor burnout and improve healthcare efficiency, Elaborate offers innovative software solutions designed to manage electronic medical records (EMR) and patient portal messages. Their core product proactively eliminates patient outreach from doctors' inbaskets, addressing one of the leading causes of physician stress and administrative burden. By embedding their technology within existing EMR systems and patient portals, Elaborate aims to enhance patient satisfaction and operational efficiency for health systems.

Elaborate has garnered attention and support from notable investors and healthcare professionals, earning accolades for its impactful approach to reducing clinician burnout. The company's achievements include significant reductions in administrative workload for doctors and improved clinical capacity for health systems. Overall, Elaborate's technology has made a substantial impact on the healthcare industry by streamlining communication processes and allowing practitioners to focus more on patient care.

Elaborate - Similar Companies

Elation Health logo

Elation Health

elationhealth.com

Notable Health logo

Notable Health

notablehealth.com

Enlyt Health logo

Enlyt Health

enlythealth.com

Elion logo

Elion

elion.health

NexHealth logo

NexHealth

nexhealth.com

eBlu Solutions logo

eBlu Solutions

eblusolutions.com

Health Note logo

Health Note

healthnote.com

Sohar Health logo

Sohar Health

soharhealth.com

eMerge Health Solutions logo

eMerge Health Solutions

Gradia Health logo

Gradia Health

gradia.com

Florence logo

Florence

fabrichealth.com

Embold Health logo

Embold Health

emboldhealth.com

Emissary Health logo

Emissary Health

Evidentia Health logo

Evidentia Health

Sopris Health logo

Sopris Health

soprishealth.com

Elaborate - Quick Facts

Who are Elaborate's competitors?

Companies similar to Elaborate include Elation Health, Notable Health, Enlyt Health and Elion.

When was Elaborate founded?

Elaborate was founded in 2021.

Where is Elaborate's headquarters located?

Elaborate's headquarters is located in New York City, NY, US.

When was Elaborate's last funding round?

Elaborate's most recent funding round was for $10M (USD) in January 2023.

How much has Elaborate raised to-date?

As of Jan 26, 2023, Elaborate has raised a total of $12.5M (USD).

How many employees does Elaborate have?

Elaborate has 22 employees as of Feb 4, 2024.

Elaborate - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified